 Nichole Carlson
Concepts (510)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bayes Theorem | 6 | 2020 | 333 | 1.350 |
Why?
| | Luteinizing Hormone | 11 | 2020 | 169 | 1.140 |
Why?
| | Models, Statistical | 6 | 2020 | 612 | 1.070 |
Why?
| | Hydrocortisone | 6 | 2015 | 273 | 0.980 |
Why?
| | Hormones | 3 | 2017 | 132 | 0.880 |
Why?
| | Emphysema | 1 | 2023 | 124 | 0.820 |
Why?
| | Hypothalamo-Hypophyseal System | 7 | 2017 | 197 | 0.770 |
Why?
| | Outpatients | 6 | 2023 | 330 | 0.740 |
Why?
| | Data Interpretation, Statistical | 3 | 2017 | 325 | 0.710 |
Why?
| | Diabetes Complications | 1 | 2022 | 212 | 0.700 |
Why?
| | Pulmonary Emphysema | 1 | 2023 | 318 | 0.700 |
Why?
| | Sarcoidosis, Pulmonary | 1 | 2019 | 58 | 0.650 |
Why?
| | Metadata | 1 | 2018 | 8 | 0.640 |
Why?
| | Radiography, Thoracic | 1 | 2019 | 165 | 0.630 |
Why?
| | Computer Simulation | 4 | 2017 | 882 | 0.620 |
Why?
| | State Health Plans | 2 | 2008 | 32 | 0.610 |
Why?
| | Follicle Stimulating Hormone | 9 | 2023 | 214 | 0.590 |
Why?
| | Models, Biological | 3 | 2017 | 1647 | 0.590 |
Why?
| | Ovary | 3 | 2017 | 190 | 0.580 |
Why?
| | Residence Characteristics | 6 | 2010 | 276 | 0.550 |
Why?
| | Genome | 1 | 2018 | 274 | 0.540 |
Why?
| | Reproduction | 1 | 2017 | 180 | 0.540 |
Why?
| | Adrenocorticotropic Hormone | 2 | 2015 | 148 | 0.540 |
Why?
| | Child Health Services | 2 | 2008 | 180 | 0.510 |
Why?
| | Software | 2 | 2019 | 542 | 0.510 |
Why?
| | Tomography, X-Ray Computed | 3 | 2019 | 2404 | 0.510 |
Why?
| | Obesity | 12 | 2023 | 2523 | 0.500 |
Why?
| | Contraceptives, Oral, Combined | 7 | 2011 | 16 | 0.490 |
Why?
| | Computational Biology | 1 | 2018 | 540 | 0.490 |
Why?
| | Brain Injuries | 5 | 2010 | 451 | 0.480 |
Why?
| | Biometry | 2 | 2017 | 63 | 0.480 |
Why?
| | Health Services for the Aged | 2 | 2019 | 70 | 0.480 |
Why?
| | Circadian Rhythm | 4 | 2013 | 371 | 0.470 |
Why?
| | Health Services Accessibility | 4 | 2010 | 771 | 0.470 |
Why?
| | Humans | 87 | 2023 | 115879 | 0.450 |
Why?
| | Antiparkinson Agents | 3 | 2009 | 26 | 0.450 |
Why?
| | Pulsatile Flow | 1 | 2013 | 54 | 0.440 |
Why?
| | Environment Design | 3 | 2010 | 24 | 0.440 |
Why?
| | Dehydroepiandrosterone | 1 | 2013 | 49 | 0.430 |
Why?
| | Female | 67 | 2023 | 60082 | 0.400 |
Why?
| | Specimen Handling | 1 | 2013 | 157 | 0.400 |
Why?
| | Saliva | 1 | 2013 | 189 | 0.390 |
Why?
| | Alzheimer Disease | 4 | 2023 | 438 | 0.390 |
Why?
| | Walking | 4 | 2010 | 426 | 0.390 |
Why?
| | Adult | 47 | 2023 | 30822 | 0.390 |
Why?
| | Gonadotropins | 3 | 2023 | 37 | 0.380 |
Why?
| | Parkinson Disease | 4 | 2009 | 325 | 0.380 |
Why?
| | White Matter | 2 | 2023 | 103 | 0.370 |
Why?
| | Levodopa | 2 | 2007 | 23 | 0.350 |
Why?
| | Activities of Daily Living | 3 | 2010 | 352 | 0.350 |
Why?
| | Aged | 24 | 2023 | 19296 | 0.350 |
Why?
| | Hypogonadism | 2 | 2015 | 74 | 0.350 |
Why?
| | Oregon | 8 | 2011 | 66 | 0.350 |
Why?
| | Endocrine System | 1 | 2009 | 20 | 0.330 |
Why?
| | Testosterone | 2 | 2010 | 337 | 0.330 |
Why?
| | Estradiol | 6 | 2023 | 453 | 0.320 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2091 | 0.310 |
Why?
| | Technology | 1 | 2009 | 78 | 0.310 |
Why?
| | Prenatal Care | 1 | 2010 | 257 | 0.310 |
Why?
| | Cerebral Ventricles | 1 | 2007 | 47 | 0.300 |
Why?
| | Levonorgestrel | 4 | 2011 | 32 | 0.300 |
Why?
| | Cognition Disorders | 3 | 2008 | 475 | 0.290 |
Why?
| | Health Behavior | 3 | 2010 | 705 | 0.290 |
Why?
| | Metrorrhagia | 3 | 2011 | 4 | 0.290 |
Why?
| | Perception | 2 | 2007 | 316 | 0.290 |
Why?
| | Young Adult | 14 | 2022 | 10510 | 0.290 |
Why?
| | Male | 39 | 2022 | 56117 | 0.280 |
Why?
| | Methylphenidate | 1 | 2007 | 36 | 0.280 |
Why?
| | Middle Aged | 32 | 2021 | 27085 | 0.280 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2007 | 54 | 0.280 |
Why?
| | Smoking Cessation | 1 | 2010 | 378 | 0.280 |
Why?
| | Aged, 80 and over | 11 | 2021 | 6434 | 0.280 |
Why?
| | Longitudinal Studies | 10 | 2020 | 2417 | 0.260 |
Why?
| | Antibodies, Viral | 4 | 2023 | 527 | 0.260 |
Why?
| | Time Factors | 13 | 2017 | 6182 | 0.260 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2022 | 3258 | 0.260 |
Why?
| | Poverty | 2 | 2010 | 444 | 0.250 |
Why?
| | Healthcare Disparities | 1 | 2010 | 487 | 0.250 |
Why?
| | Cluster Analysis | 2 | 2023 | 466 | 0.250 |
Why?
| | Gliosis | 2 | 2023 | 30 | 0.240 |
Why?
| | Lung | 3 | 2023 | 3683 | 0.230 |
Why?
| | Medicaid | 1 | 2008 | 411 | 0.230 |
Why?
| | Body Mass Index | 6 | 2019 | 1974 | 0.220 |
Why?
| | Socioeconomic Factors | 5 | 2010 | 1088 | 0.210 |
Why?
| | Oocytes | 2 | 2020 | 172 | 0.210 |
Why?
| | Cross-Sectional Studies | 12 | 2018 | 4447 | 0.210 |
Why?
| | Prospective Studies | 9 | 2023 | 6279 | 0.210 |
Why?
| | Aging | 4 | 2008 | 1635 | 0.210 |
Why?
| | Hospitalization | 6 | 2022 | 1766 | 0.200 |
Why?
| | Benchmarking | 1 | 2023 | 163 | 0.200 |
Why?
| | Markov Chains | 3 | 2017 | 115 | 0.200 |
Why?
| | Monte Carlo Method | 3 | 2017 | 140 | 0.200 |
Why?
| | Disability Evaluation | 4 | 2018 | 271 | 0.190 |
Why?
| | Weight Gain | 2 | 2022 | 454 | 0.190 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2022 | 71 | 0.190 |
Why?
| | Healthy Aging | 1 | 2021 | 17 | 0.190 |
Why?
| | Doxycycline | 2 | 2011 | 56 | 0.190 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2021 | 82 | 0.180 |
Why?
| | Ethinyl Estradiol | 2 | 2011 | 17 | 0.180 |
Why?
| | Oocyte Donation | 1 | 2020 | 4 | 0.180 |
Why?
| | Preimplantation Diagnosis | 1 | 2020 | 4 | 0.180 |
Why?
| | Memory, Episodic | 1 | 2021 | 38 | 0.180 |
Why?
| | Prescription Drugs | 1 | 2022 | 116 | 0.180 |
Why?
| | Sarcoidosis | 1 | 2022 | 134 | 0.180 |
Why?
| | Reproductive Techniques, Assisted | 1 | 2020 | 32 | 0.180 |
Why?
| | Apomorphine | 3 | 2009 | 5 | 0.170 |
Why?
| | Menstruation | 2 | 1991 | 35 | 0.170 |
Why?
| | Quality of Life | 5 | 2018 | 2390 | 0.170 |
Why?
| | Aromatase Inhibitors | 1 | 2020 | 49 | 0.170 |
Why?
| | Fractals | 1 | 2019 | 6 | 0.170 |
Why?
| | Cytomegalovirus Infections | 1 | 2022 | 181 | 0.170 |
Why?
| | Comprehensive Health Care | 1 | 2019 | 19 | 0.170 |
Why?
| | Internet | 2 | 2018 | 601 | 0.170 |
Why?
| | Radial Nerve | 1 | 1999 | 10 | 0.170 |
Why?
| | Nerve Compression Syndromes | 1 | 1999 | 26 | 0.170 |
Why?
| | Human Growth Hormone | 2 | 2014 | 38 | 0.170 |
Why?
| | Astrocytes | 1 | 2021 | 165 | 0.170 |
Why?
| | Health Status | 3 | 2010 | 728 | 0.170 |
Why?
| | Spirometry | 1 | 2019 | 256 | 0.160 |
Why?
| | Proportional Hazards Models | 3 | 2017 | 1088 | 0.160 |
Why?
| | Vital Capacity | 1 | 2019 | 279 | 0.160 |
Why?
| | Hip Fractures | 1 | 2019 | 75 | 0.160 |
Why?
| | Datasets as Topic | 1 | 2018 | 99 | 0.160 |
Why?
| | Bibliometrics | 1 | 2018 | 45 | 0.160 |
Why?
| | Contraception | 2 | 1991 | 118 | 0.150 |
Why?
| | Risk Factors | 9 | 2022 | 8715 | 0.150 |
Why?
| | Sheep, Domestic | 1 | 2017 | 33 | 0.150 |
Why?
| | Regression Analysis | 2 | 2019 | 960 | 0.150 |
Why?
| | Algorithms | 3 | 2017 | 1494 | 0.150 |
Why?
| | Respiratory Function Tests | 1 | 2019 | 539 | 0.150 |
Why?
| | Rhinitis | 2 | 2010 | 128 | 0.150 |
Why?
| | Eligibility Determination | 2 | 2008 | 60 | 0.150 |
Why?
| | Reproductive Physiological Phenomena | 1 | 2017 | 1 | 0.150 |
Why?
| | Pregnancy | 8 | 2023 | 5555 | 0.150 |
Why?
| | Premature Birth | 1 | 2020 | 278 | 0.150 |
Why?
| | Psychomotor Performance | 3 | 2009 | 278 | 0.140 |
Why?
| | Lactation | 1 | 2018 | 149 | 0.140 |
Why?
| | Medically Uninsured | 2 | 2008 | 122 | 0.140 |
Why?
| | Affect | 3 | 2008 | 244 | 0.140 |
Why?
| | Double-Blind Method | 7 | 2011 | 1664 | 0.140 |
Why?
| | Family Planning Services | 2 | 2008 | 67 | 0.140 |
Why?
| | Metabolic Diseases | 1 | 2018 | 99 | 0.140 |
Why?
| | Adolescent | 13 | 2020 | 17940 | 0.140 |
Why?
| | Sinusitis | 2 | 2010 | 175 | 0.140 |
Why?
| | Cohort Studies | 5 | 2010 | 4960 | 0.140 |
Why?
| | Hypothyroidism | 2 | 2007 | 65 | 0.140 |
Why?
| | Proton Pump Inhibitors | 1 | 2017 | 96 | 0.140 |
Why?
| | Endoscopy | 2 | 2010 | 247 | 0.140 |
Why?
| | Reproducibility of Results | 2 | 2017 | 2807 | 0.140 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 223 | 0.140 |
Why?
| | Retrospective Studies | 10 | 2023 | 12616 | 0.140 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2018 | 141 | 0.140 |
Why?
| | Low Back Pain | 1 | 2018 | 95 | 0.140 |
Why?
| | Immunologic Memory | 1 | 2018 | 312 | 0.140 |
Why?
| | Antibodies | 1 | 2018 | 374 | 0.140 |
Why?
| | Dietary Fats | 1 | 2018 | 291 | 0.130 |
Why?
| | Models, Animal | 1 | 2017 | 350 | 0.130 |
Why?
| | Brain | 5 | 2023 | 2372 | 0.130 |
Why?
| | Personnel Selection | 1 | 2016 | 67 | 0.130 |
Why?
| | Cross-Over Studies | 5 | 2009 | 437 | 0.130 |
Why?
| | Recovery of Function | 2 | 2010 | 577 | 0.130 |
Why?
| | Otolaryngology | 1 | 2016 | 71 | 0.130 |
Why?
| | Patient Dropouts | 1 | 2015 | 65 | 0.120 |
Why?
| | Pulmonary Embolism | 1 | 2017 | 182 | 0.120 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2015 | 103 | 0.120 |
Why?
| | Dementia | 2 | 2008 | 185 | 0.120 |
Why?
| | Biomarkers | 4 | 2021 | 3474 | 0.120 |
Why?
| | Breast Feeding | 1 | 2018 | 370 | 0.120 |
Why?
| | Menstrual Cycle | 3 | 2011 | 109 | 0.120 |
Why?
| | Acromegaly | 1 | 2014 | 12 | 0.120 |
Why?
| | Growth Hormone-Secreting Pituitary Adenoma | 1 | 2014 | 11 | 0.120 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2015 | 125 | 0.120 |
Why?
| | Pituitary-Adrenal System | 3 | 2013 | 162 | 0.120 |
Why?
| | Decision Support Systems, Clinical | 1 | 2017 | 180 | 0.120 |
Why?
| | Gonadotropin-Releasing Hormone | 4 | 2020 | 193 | 0.120 |
Why?
| | Brain Ischemia | 1 | 2017 | 298 | 0.120 |
Why?
| | Analysis of Variance | 5 | 2009 | 1227 | 0.120 |
Why?
| | Drug Administration Schedule | 4 | 2010 | 724 | 0.110 |
Why?
| | Health Care Costs | 1 | 2017 | 384 | 0.110 |
Why?
| | Antibody Formation | 2 | 2022 | 274 | 0.110 |
Why?
| | Interviews as Topic | 3 | 2010 | 596 | 0.110 |
Why?
| | Arthritis, Rheumatoid | 1 | 2022 | 1003 | 0.110 |
Why?
| | Secretory Rate | 1 | 2013 | 16 | 0.110 |
Why?
| | Arrhythmias, Cardiac | 1 | 2015 | 279 | 0.110 |
Why?
| | Neurosurgical Procedures | 1 | 2014 | 157 | 0.110 |
Why?
| | Electronics | 1 | 2013 | 68 | 0.110 |
Why?
| | Immunoenzyme Techniques | 1 | 2013 | 193 | 0.110 |
Why?
| | Education, Medical, Graduate | 1 | 2016 | 378 | 0.100 |
Why?
| | Severity of Illness Index | 5 | 2022 | 2590 | 0.100 |
Why?
| | Adenoma | 1 | 2014 | 187 | 0.100 |
Why?
| | Age Factors | 8 | 2018 | 2911 | 0.100 |
Why?
| | Medical Records | 1 | 2013 | 157 | 0.100 |
Why?
| | Insulin | 1 | 2022 | 2084 | 0.100 |
Why?
| | Antibodies, Monoclonal | 3 | 2022 | 1264 | 0.100 |
Why?
| | Cognition | 3 | 2008 | 980 | 0.100 |
Why?
| | Wakefulness | 1 | 2013 | 128 | 0.100 |
Why?
| | Follow-Up Studies | 5 | 2017 | 4444 | 0.100 |
Why?
| | Ventricular Function, Left | 1 | 2015 | 469 | 0.100 |
Why?
| | Memory | 3 | 2008 | 211 | 0.100 |
Why?
| | Urban Health | 2 | 2009 | 75 | 0.100 |
Why?
| | Dietary Supplements | 1 | 2015 | 460 | 0.100 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2015 | 366 | 0.100 |
Why?
| | Statistics as Topic | 2 | 2009 | 299 | 0.100 |
Why?
| | Progestins | 1 | 2011 | 75 | 0.100 |
Why?
| | Risk Assessment | 2 | 2017 | 2992 | 0.100 |
Why?
| | Amenorrhea | 1 | 2011 | 27 | 0.100 |
Why?
| | Dopamine Agonists | 2 | 2008 | 31 | 0.090 |
Why?
| | Equipment Design | 1 | 2013 | 518 | 0.090 |
Why?
| | Cytokines | 2 | 2015 | 1858 | 0.090 |
Why?
| | Diet | 1 | 2018 | 1074 | 0.090 |
Why?
| | Contraceptives, Oral, Hormonal | 2 | 2007 | 23 | 0.090 |
Why?
| | Birth Certificates | 1 | 2010 | 8 | 0.090 |
Why?
| | Automobile Driving | 2 | 2010 | 129 | 0.090 |
Why?
| | Estrone | 1 | 2010 | 35 | 0.090 |
Why?
| | Birth Rate | 2 | 2020 | 20 | 0.090 |
Why?
| | Myocardial Infarction | 1 | 2017 | 932 | 0.090 |
Why?
| | Dihydrotestosterone | 1 | 2010 | 39 | 0.090 |
Why?
| | Live Birth | 2 | 2020 | 48 | 0.090 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 2010 | 13 | 0.090 |
Why?
| | United States | 6 | 2020 | 12322 | 0.090 |
Why?
| | Pregnancy Rate | 2 | 2020 | 55 | 0.090 |
Why?
| | Geographic Information Systems | 2 | 2010 | 37 | 0.090 |
Why?
| | Fertilization in Vitro | 2 | 2020 | 71 | 0.090 |
Why?
| | Thyroxine | 2 | 2007 | 59 | 0.090 |
Why?
| | Sex Factors | 5 | 2018 | 1741 | 0.090 |
Why?
| | Cities | 1 | 2010 | 81 | 0.090 |
Why?
| | Abortion, Induced | 2 | 2008 | 73 | 0.090 |
Why?
| | Registries | 1 | 2017 | 1772 | 0.090 |
Why?
| | Personality | 1 | 2011 | 114 | 0.090 |
Why?
| | Exercise | 3 | 2010 | 1612 | 0.080 |
Why?
| | Treatment Outcome | 7 | 2015 | 9164 | 0.080 |
Why?
| | Electrical Equipment and Supplies | 1 | 2009 | 8 | 0.080 |
Why?
| | Child, Preschool | 4 | 2018 | 9165 | 0.080 |
Why?
| | Rehabilitation Centers | 1 | 2009 | 32 | 0.080 |
Why?
| | Independent Living | 1 | 2010 | 84 | 0.080 |
Why?
| | Mortality | 1 | 2011 | 290 | 0.080 |
Why?
| | Telecommunications | 1 | 2009 | 16 | 0.080 |
Why?
| | Pattern Recognition, Automated | 1 | 2009 | 71 | 0.080 |
Why?
| | Progesterone | 3 | 2015 | 232 | 0.080 |
Why?
| | Postmenopause | 1 | 2010 | 301 | 0.080 |
Why?
| | Rural Health | 1 | 2009 | 68 | 0.080 |
Why?
| | Drug Interactions | 2 | 2007 | 347 | 0.080 |
Why?
| | Logistic Models | 2 | 2010 | 1863 | 0.080 |
Why?
| | Foot | 1 | 2009 | 104 | 0.080 |
Why?
| | Thyrotoxicosis | 1 | 2008 | 8 | 0.080 |
Why?
| | Life Change Events | 1 | 2009 | 135 | 0.080 |
Why?
| | Monitoring, Ambulatory | 1 | 2009 | 82 | 0.080 |
Why?
| | Disease Progression | 3 | 2015 | 2423 | 0.080 |
Why?
| | Ointments | 1 | 2007 | 23 | 0.080 |
Why?
| | Vaccinia | 1 | 2007 | 19 | 0.080 |
Why?
| | Pregnancy, Unplanned | 1 | 2008 | 33 | 0.080 |
Why?
| | Povidone-Iodine | 1 | 2007 | 11 | 0.080 |
Why?
| | Vaccinia virus | 1 | 2007 | 30 | 0.080 |
Why?
| | Smallpox Vaccine | 1 | 2007 | 23 | 0.080 |
Why?
| | Counseling | 1 | 2010 | 346 | 0.070 |
Why?
| | CD4 Lymphocyte Count | 2 | 2020 | 257 | 0.070 |
Why?
| | Population Surveillance | 1 | 2010 | 395 | 0.070 |
Why?
| | Parkinsonian Disorders | 1 | 2007 | 27 | 0.070 |
Why?
| | Atrophy | 1 | 2007 | 152 | 0.070 |
Why?
| | Dyskinesia, Drug-Induced | 1 | 2007 | 11 | 0.070 |
Why?
| | Antigens, Bacterial | 1 | 2007 | 112 | 0.070 |
Why?
| | Time Perception | 1 | 2007 | 24 | 0.070 |
Why?
| | Internship and Residency | 1 | 2016 | 957 | 0.070 |
Why?
| | Awareness | 1 | 2007 | 91 | 0.070 |
Why?
| | Antibodies, Bacterial | 1 | 2007 | 119 | 0.070 |
Why?
| | Antigens, Viral | 1 | 2007 | 177 | 0.070 |
Why?
| | Movement | 1 | 2009 | 246 | 0.070 |
Why?
| | Albumins | 1 | 2007 | 91 | 0.070 |
Why?
| | Tremor | 1 | 2007 | 45 | 0.070 |
Why?
| | Suicide, Attempted | 1 | 2009 | 316 | 0.070 |
Why?
| | Infant | 3 | 2010 | 7992 | 0.070 |
Why?
| | Wounds, Gunshot | 1 | 2009 | 187 | 0.070 |
Why?
| | Blood-Brain Barrier | 1 | 2007 | 106 | 0.070 |
Why?
| | Emergency Service, Hospital | 1 | 2017 | 1842 | 0.070 |
Why?
| | Cost-Benefit Analysis | 1 | 2009 | 548 | 0.070 |
Why?
| | Animals | 6 | 2023 | 32162 | 0.060 |
Why?
| | Paroxetine | 1 | 2005 | 7 | 0.060 |
Why?
| | Treatment Failure | 2 | 2022 | 332 | 0.060 |
Why?
| | Health Policy | 1 | 2008 | 334 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1725 | 0.060 |
Why?
| | Attitude to Health | 1 | 2008 | 409 | 0.060 |
Why?
| | Administration, Oral | 1 | 2007 | 734 | 0.060 |
Why?
| | Neurologic Examination | 2 | 2008 | 116 | 0.060 |
Why?
| | Child | 5 | 2018 | 18539 | 0.060 |
Why?
| | Sexual Behavior | 1 | 2008 | 440 | 0.060 |
Why?
| | Health Promotion | 1 | 2010 | 690 | 0.060 |
Why?
| | Patient Compliance | 1 | 2008 | 524 | 0.060 |
Why?
| | Family | 1 | 2008 | 597 | 0.060 |
Why?
| | Likelihood Functions | 2 | 2017 | 129 | 0.060 |
Why?
| | Follicle Stimulating Hormone, Human | 1 | 2023 | 11 | 0.060 |
Why?
| | Neurites | 1 | 2023 | 43 | 0.050 |
Why?
| | Linear Models | 2 | 2020 | 777 | 0.050 |
Why?
| | Sex Characteristics | 1 | 2007 | 643 | 0.050 |
Why?
| | Diffusion Tensor Imaging | 1 | 2023 | 66 | 0.050 |
Why?
| | Emotions | 1 | 2007 | 480 | 0.050 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2023 | 85 | 0.050 |
Why?
| | Motor Activity | 1 | 2007 | 635 | 0.050 |
Why?
| | Physical Fitness | 1 | 2004 | 179 | 0.050 |
Why?
| | Practice Patterns, Physicians' | 1 | 2011 | 1182 | 0.050 |
Why?
| | B-Lymphocytes | 1 | 2007 | 771 | 0.050 |
Why?
| | Vaccines | 1 | 2007 | 376 | 0.050 |
Why?
| | Temporomandibular Joint Dysfunction Syndrome | 1 | 2002 | 2 | 0.050 |
Why?
| | Ritonavir | 1 | 2023 | 72 | 0.050 |
Why?
| | Facial Pain | 1 | 2002 | 12 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 3 | 2008 | 3072 | 0.050 |
Why?
| | Anti-Bacterial Agents | 1 | 2011 | 1486 | 0.050 |
Why?
| | Physical Examination | 2 | 2018 | 224 | 0.050 |
Why?
| | Acids | 1 | 2002 | 17 | 0.050 |
Why?
| | Administration, Cutaneous | 2 | 2015 | 116 | 0.050 |
Why?
| | Odds Ratio | 3 | 2010 | 968 | 0.050 |
Why?
| | Patient Acceptance of Health Care | 1 | 2007 | 682 | 0.050 |
Why?
| | Ovarian Follicle | 1 | 2002 | 61 | 0.050 |
Why?
| | Herpesvirus 4, Human | 1 | 2022 | 123 | 0.050 |
Why?
| | Breast Neoplasms | 2 | 2011 | 1872 | 0.050 |
Why?
| | Neuroimaging | 1 | 2023 | 248 | 0.050 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2022 | 90 | 0.050 |
Why?
| | Rheumatoid Factor | 1 | 2022 | 157 | 0.050 |
Why?
| | Puberty | 1 | 2002 | 137 | 0.050 |
Why?
| | Immunoglobulin A | 1 | 2022 | 173 | 0.050 |
Why?
| | Leptin | 1 | 2002 | 211 | 0.050 |
Why?
| | Oocyte Retrieval | 1 | 2020 | 11 | 0.050 |
Why?
| | Fasting | 1 | 2002 | 241 | 0.050 |
Why?
| | Pregnancy, Multiple | 1 | 2020 | 14 | 0.050 |
Why?
| | Immunoglobulin M | 1 | 2022 | 251 | 0.050 |
Why?
| | Blastocyst | 1 | 2020 | 43 | 0.050 |
Why?
| | Embryo Transfer | 1 | 2020 | 29 | 0.040 |
Why?
| | Case-Control Studies | 4 | 2009 | 3054 | 0.040 |
Why?
| | Prostaglandins | 1 | 2000 | 78 | 0.040 |
Why?
| | Radionuclide Imaging | 1 | 2019 | 121 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2009 | 1871 | 0.040 |
Why?
| | Depression | 1 | 2008 | 1147 | 0.040 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2007 | 1193 | 0.040 |
Why?
| | Endotoxins | 1 | 2000 | 208 | 0.040 |
Why?
| | Decompression, Surgical | 1 | 1999 | 93 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 1814 | 0.040 |
Why?
| | Immunization, Secondary | 1 | 2018 | 82 | 0.040 |
Why?
| | Depressive Disorder, Major | 1 | 2001 | 304 | 0.040 |
Why?
| | Denmark | 1 | 2017 | 40 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2022 | 782 | 0.040 |
Why?
| | Electromyography | 1 | 1999 | 325 | 0.040 |
Why?
| | Genetic Testing | 1 | 2020 | 383 | 0.040 |
Why?
| | Incidence | 2 | 2017 | 2336 | 0.040 |
Why?
| | Depressive Disorder | 1 | 2000 | 336 | 0.040 |
Why?
| | Controlled Before-After Studies | 1 | 2017 | 14 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2008 | 309 | 0.040 |
Why?
| | Viruses | 1 | 2018 | 94 | 0.040 |
Why?
| | Psychological Tests | 1 | 2018 | 123 | 0.040 |
Why?
| | Antiviral Agents | 1 | 2023 | 651 | 0.040 |
Why?
| | Milk | 1 | 2018 | 124 | 0.040 |
Why?
| | Neoplasms | 1 | 2011 | 2115 | 0.040 |
Why?
| | Biostatistics | 1 | 2017 | 17 | 0.040 |
Why?
| | Signal-To-Noise Ratio | 1 | 2017 | 57 | 0.040 |
Why?
| | Thyrotropin | 2 | 2007 | 100 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2018 | 225 | 0.030 |
Why?
| | Health Surveys | 2 | 2009 | 447 | 0.030 |
Why?
| | Drug Combinations | 2 | 2011 | 289 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2000 | 832 | 0.030 |
Why?
| | Survival Analysis | 1 | 2019 | 1218 | 0.030 |
Why?
| | Escherichia coli | 1 | 2000 | 730 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 796 | 0.030 |
Why?
| | Fatty Liver | 1 | 2018 | 217 | 0.030 |
Why?
| | Gastrointestinal Diseases | 1 | 2017 | 184 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2015 | 54 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 1999 | 1359 | 0.030 |
Why?
| | Systole | 1 | 2015 | 169 | 0.030 |
Why?
| | Drug Users | 1 | 2015 | 41 | 0.030 |
Why?
| | Electric Countershock | 1 | 2015 | 104 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2015 | 221 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 783 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2015 | 1138 | 0.030 |
Why?
| | Risk | 1 | 2017 | 829 | 0.030 |
Why?
| | Psychometrics | 1 | 2018 | 615 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2018 | 4780 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2018 | 553 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2018 | 3587 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2015 | 501 | 0.030 |
Why?
| | Death, Sudden, Cardiac | 1 | 2015 | 160 | 0.030 |
Why?
| | Phenotype | 1 | 2022 | 2859 | 0.030 |
Why?
| | Phospholipids | 1 | 2015 | 202 | 0.030 |
Why?
| | Substance Abuse, Intravenous | 1 | 2015 | 99 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2015 | 621 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2015 | 370 | 0.030 |
Why?
| | Neuropsychological Tests | 2 | 2008 | 919 | 0.030 |
Why?
| | Colorado | 1 | 2023 | 4122 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2015 | 816 | 0.030 |
Why?
| | Estrogens | 1 | 2015 | 316 | 0.030 |
Why?
| | Follicular Phase | 2 | 2004 | 37 | 0.030 |
Why?
| | Fatty Acids | 1 | 2015 | 386 | 0.030 |
Why?
| | Feeding Behavior | 1 | 2018 | 574 | 0.030 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 450 | 0.030 |
Why?
| | Mothers | 1 | 2018 | 666 | 0.030 |
Why?
| | Defibrillators, Implantable | 1 | 2015 | 286 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2015 | 1443 | 0.020 |
Why?
| | Prognosis | 1 | 1999 | 3344 | 0.020 |
Why?
| | Electronic Health Records | 1 | 2017 | 805 | 0.020 |
Why?
| | Abbreviated Injury Scale | 1 | 2010 | 21 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 5084 | 0.020 |
Why?
| | Life Expectancy | 1 | 2010 | 51 | 0.020 |
Why?
| | Nasal Polyps | 1 | 2010 | 49 | 0.020 |
Why?
| | Trauma Severity Indices | 1 | 2010 | 111 | 0.020 |
Why?
| | Heart-Assist Devices | 1 | 2015 | 486 | 0.020 |
Why?
| | Glasgow Coma Scale | 1 | 2010 | 144 | 0.020 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2015 | 967 | 0.020 |
Why?
| | Amides | 1 | 2010 | 89 | 0.020 |
Why?
| | Heart Transplantation | 1 | 2015 | 671 | 0.020 |
Why?
| | Reference Values | 1 | 2010 | 745 | 0.020 |
Why?
| | Income | 1 | 2010 | 170 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2010 | 346 | 0.020 |
Why?
| | Benzodioxoles | 1 | 2010 | 83 | 0.020 |
Why?
| | Obstetrics | 1 | 2011 | 161 | 0.020 |
Why?
| | Family Characteristics | 1 | 2010 | 154 | 0.020 |
Why?
| | Norgestrel | 1 | 1988 | 2 | 0.020 |
Why?
| | Medroxyprogesterone | 1 | 1988 | 10 | 0.020 |
Why?
| | Administration, Intravaginal | 1 | 1988 | 20 | 0.020 |
Why?
| | Medroxyprogesterone Acetate | 1 | 1988 | 29 | 0.020 |
Why?
| | Employment | 1 | 2010 | 139 | 0.020 |
Why?
| | Poverty Areas | 1 | 2008 | 33 | 0.020 |
Why?
| | Sheep | 2 | 2002 | 766 | 0.020 |
Why?
| | Thyroid Function Tests | 1 | 2008 | 11 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2009 | 256 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2010 | 414 | 0.020 |
Why?
| | Receptors, Dopamine | 1 | 2008 | 12 | 0.020 |
Why?
| | Parity | 1 | 1988 | 99 | 0.020 |
Why?
| | Intelligence Tests | 1 | 2008 | 59 | 0.020 |
Why?
| | Gynecology | 1 | 2011 | 185 | 0.020 |
Why?
| | Personal Satisfaction | 1 | 2010 | 185 | 0.020 |
Why?
| | Smallpox | 1 | 2007 | 7 | 0.020 |
Why?
| | Surveys and Questionnaires | 2 | 2011 | 4675 | 0.020 |
Why?
| | Diphtheria | 1 | 2007 | 20 | 0.020 |
Why?
| | Galvanic Skin Response | 1 | 2007 | 26 | 0.020 |
Why?
| | Commerce | 1 | 2008 | 61 | 0.020 |
Why?
| | Tetanus | 1 | 2007 | 25 | 0.020 |
Why?
| | Cause of Death | 1 | 2010 | 368 | 0.020 |
Why?
| | Educational Status | 1 | 2010 | 413 | 0.020 |
Why?
| | Virus Shedding | 1 | 2007 | 39 | 0.020 |
Why?
| | Half-Life | 1 | 2007 | 145 | 0.020 |
Why?
| | Lymphocyte Count | 1 | 2007 | 133 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 445 | 0.020 |
Why?
| | Contraindications | 1 | 2007 | 86 | 0.020 |
Why?
| | Plasma Cells | 1 | 2007 | 57 | 0.020 |
Why?
| | Seroepidemiologic Studies | 1 | 2007 | 141 | 0.020 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2007 | 41 | 0.020 |
Why?
| | Triiodothyronine | 1 | 2007 | 43 | 0.020 |
Why?
| | Apolipoproteins E | 1 | 2007 | 81 | 0.020 |
Why?
| | Family Practice | 1 | 2011 | 428 | 0.020 |
Why?
| | Photic Stimulation | 1 | 2007 | 203 | 0.020 |
Why?
| | Thyroid Hormones | 1 | 2007 | 53 | 0.020 |
Why?
| | Research | 1 | 2010 | 398 | 0.020 |
Why?
| | Thyroid Gland | 1 | 2007 | 83 | 0.020 |
Why?
| | Cerebrovascular Disorders | 1 | 2007 | 82 | 0.020 |
Why?
| | Neural Inhibition | 1 | 2007 | 152 | 0.020 |
Why?
| | Age of Onset | 1 | 2008 | 455 | 0.020 |
Why?
| | Safety | 1 | 2008 | 298 | 0.020 |
Why?
| | Motor Skills | 1 | 2007 | 80 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2010 | 585 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2008 | 485 | 0.020 |
Why?
| | Mental Recall | 1 | 2007 | 173 | 0.020 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2007 | 293 | 0.020 |
Why?
| | Dopamine Agents | 1 | 2005 | 13 | 0.020 |
Why?
| | Virus Diseases | 1 | 2007 | 200 | 0.020 |
Why?
| | Inpatients | 1 | 2009 | 380 | 0.020 |
Why?
| | Length of Stay | 1 | 2009 | 960 | 0.020 |
Why?
| | Vestibular Diseases | 1 | 2005 | 22 | 0.020 |
Why?
| | Comorbidity | 1 | 2010 | 1476 | 0.020 |
Why?
| | Down-Regulation | 1 | 2007 | 605 | 0.020 |
Why?
| | Presynaptic Terminals | 1 | 2005 | 55 | 0.020 |
Why?
| | Dizziness | 1 | 2005 | 70 | 0.020 |
Why?
| | Self Efficacy | 1 | 2008 | 361 | 0.020 |
Why?
| | Gait Disorders, Neurologic | 1 | 2005 | 38 | 0.020 |
Why?
| | Memory, Short-Term | 1 | 2007 | 224 | 0.020 |
Why?
| | Research Design | 1 | 2010 | 949 | 0.010 |
Why?
| | Chronic Disease | 1 | 2010 | 1598 | 0.010 |
Why?
| | Diet Records | 1 | 2004 | 76 | 0.010 |
Why?
| | Overweight | 1 | 2008 | 468 | 0.010 |
Why?
| | Menarche | 1 | 2004 | 49 | 0.010 |
Why?
| | Skin | 1 | 2007 | 668 | 0.010 |
Why?
| | Caregivers | 1 | 2010 | 713 | 0.010 |
Why?
| | Serotonin | 1 | 2005 | 296 | 0.010 |
Why?
| | Accidental Falls | 1 | 2005 | 151 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2008 | 1217 | 0.010 |
Why?
| | Stress, Psychological | 1 | 2011 | 976 | 0.010 |
Why?
| | Dopamine | 1 | 2005 | 237 | 0.010 |
Why?
| | Heart Failure | 1 | 2015 | 1963 | 0.010 |
Why?
| | Contraceptives, Oral | 1 | 2002 | 25 | 0.010 |
Why?
| | Follicular Fluid | 1 | 2002 | 5 | 0.010 |
Why?
| | Adrenal Cortex | 1 | 2002 | 32 | 0.010 |
Why?
| | Neuraminidase | 1 | 2002 | 22 | 0.010 |
Why?
| | Hormone Antagonists | 1 | 2002 | 38 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 2002 | 178 | 0.010 |
Why?
| | Dipeptides | 1 | 2002 | 49 | 0.010 |
Why?
| | Thinness | 1 | 2002 | 87 | 0.010 |
Why?
| | Postprandial Period | 1 | 2002 | 88 | 0.010 |
Why?
| | Energy Intake | 1 | 2004 | 413 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2004 | 573 | 0.010 |
Why?
| | Pituitary Gland | 1 | 2002 | 152 | 0.010 |
Why?
| | HIV Infections | 1 | 2015 | 2471 | 0.010 |
Why?
| | Periodicity | 1 | 2000 | 56 | 0.010 |
Why?
| | Luteal Phase | 1 | 2000 | 41 | 0.010 |
Why?
| | Area Under Curve | 1 | 2001 | 277 | 0.010 |
Why?
| | Protein Isoforms | 1 | 2002 | 339 | 0.010 |
Why?
| | Prostaglandin Antagonists | 1 | 2000 | 2 | 0.010 |
Why?
| | Flurbiprofen | 1 | 2000 | 3 | 0.010 |
Why?
| | Depression, Chemical | 1 | 2000 | 23 | 0.010 |
Why?
| | Pain Measurement | 1 | 2002 | 449 | 0.010 |
Why?
| | Vaccination | 1 | 2007 | 1210 | 0.010 |
Why?
| | Hypertension | 1 | 2007 | 1065 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2007 | 2201 | 0.010 |
Why?
| | Fever | 1 | 2000 | 280 | 0.010 |
Why?
| | Sleep | 1 | 2002 | 625 | 0.010 |
Why?
| | Mice | 1 | 2007 | 15087 | 0.010 |
Why?
|
|
Carlson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|